As i understand it, as early as in two weeks time, LDX is...

As i understand it, as early as in two weeks time, LDX is expecting a decision from the US Govt on the potential cost reimbursement by the US Govt to clinicians and facilities who buy and use FebriDX.

This development is mentioned in the recent Investor Presentation (as highlighted below) and in an article about LDX which has been recently published (also highlighted below).

If the US Govt does provide cost reimbursement for the use of FebriDX in the USA, then as the below article states "if there is positive incentive for adoption such as the clinician or facility getting paid (to use FebriDX), then they will use the product"

IMO this will be a significant announcement, and it is due to be released in the very near future.